C. Stephen Foster, M.D.
In Print (801-850)
801. Mehta M, Rasheed RA, Duker J, Reichel E, Feinberg E, Husain D, Foster CS, Laver NV. Vitreous Evaluation: A Diagnostic Challenge. Ophthalmology. 2015 Mar;122(3):531-7.
802. Preble J, Foster CS. Uveitic Macular Edema: A Stepladder Treatment Paradigm. Clinical Investigation, 2015;5(6):509-17.
803. Letko E, Yeh S, Foster CS, Pleyer U, Brigell M, Grosskreutz CL; AIN457A2208 Study Group. Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy. Ophthalmology. 2015 May;122(5):939-48.
804. Kruh JN, Kruh-Garcia NA, Foster CS. Evaluation of the Effect of N-Acetylcysteine on Protein Deposition on Contact Lenses in Patients with the Boston Keratoprosthesis Type I. J Ocul Pharmacol Ther. 2015 Jul-Aug;31(6):314-22.
805. Metzinger JL, Foster CS. Approved for use in uveitis’: drug approval for an orphan disease. Expert Opin Orphan Drugs. 2015 Jul;3(7):799-807
806. Cocho L, Swan RT, Foster CS. Are Patients being treated with immunosuppression for ocular inflammatory disease adequately. Expert Rev Ophthalmol. 2015 Aug;10(4):341-50.
807. Arcinue CA, Durrani KD, Artornsombudh P, Radwan A, Parikh R, Suelves A, Siddique S, Chang I, Preble J, Foster CS. Efficacy and Safety of Adalimumab for Intraocular Inflammation. Orphan Drugs: Research and Reviews. 2015 Aug;5:69-74.
808. Kothari S, Foster CS, Pistilli M, Liesegang TL, Daniel E, Sen HN, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Lawrence SD, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Research Group. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis. Ophthalmology. 2015 Oct;122(10):1987-2001.
809. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. Ophthalmology. 2015 Oct;122(10):1967-75.
810. Multicenter Uveitis Steroid Treatment (MUST) Trial Follow-up Study Research Group. Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study.Ophthalmology. 2015 Oct;122(10):1976-86.
811. Tomkins-Netzer O, Lightman S, Drye L, Kempen J, Holland GN, Rao NA, Stawell RJ, Vitale A, Jabs DA, Multicenter Uveitis Steroid Treatment Trial Research Group. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Ophthalmology. 2015 Nov;122(11):2351-9.
812. Preble JM, Silpa-Archa S, Foster CS. Ocular Involvement in Systemic Lupus Erythematosus. Curr Opin Ophthalmol. 2015 Nov;26(6):540-5.
813. Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group; Multicenter Uveitis Steroid Treatment MUST Trial Research Group. Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial. Am J Ophthalmol. 2015 Dec;160(6):1133-1141.e9.
814. Freitas-Neto CA, Maghsoudlou A, Dhanireddy S, Payal A, Boonsopon S, Ratwatte MD, Foster CS. Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants. Ocul Immunol Inflamm. 2015 Dec;23(6):425-9.
815. Sharma PK, Markov GT, Bajwa A, Foster CS. Long-term efficacy of systemic infliximab in recalcitrant retinal vasculitis. Retina. 2015 Dec;35(12):2641-6.
816. Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr Virus Early Antigen D IgG Titers. Eur J Ophthalmol. 2015 Dec 1;26(1):30-5.
817. Silpa-Archa S, Lee JJ, Foster CS. Ocular manifestations in systemic lupus erythematosus. Br J Ophthalmol. 2016 Jan;100(1):135-41.
818. Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial. Ophthalmology. 2016 Jan;123(1):183-90.
819. Freitas-Neto CA, Cao JH, Oréfice JL, Costa RA, Oréfice F, Lee J, Payal A, Foster CS. Increased Submacular Choroidal Thickness in Active, Isolated, Extramacular Toxoplasmosis. Ophthalmology. 2016 Jan; 123(1):222-224.
820. Foster CS, Kothari S, Anesi SD, Vitale AD, Chu D, Metzinger JL, Cerón O. The Ocular Immunology and Uveitis Foundation (OIUF) Preferred Practice Patterns of Uveitis Management. Surv Ophthalmol. 2016 Jan-Feb;61(1):1-17.
821. Abu Samra K, Sahawneh H, Foster CS. The role of biologic response modifiers in the management of Juvenile Idiopathic Arthritis associated Uveitis: a review. Expert Review of Ophthalomology. 21 Mar 2016.
822. Maleki A, Swan RT, Silpa-Archa S, Preble J, He Y, Foster CS. Short-Wavelength Automated Perimetry Parameters at Baseline and Following Remission in Patients with Birdshot Retinochoroidopathy. Am J Ophthalmol. 2016 Mar;163:83-92
823. Castiblanco C, Meese H, Foster CS. Treatment of Pediatric Uveitis with Adalimumab: The MERSI Experience. Journal of the American Association for Pediatric Ophthalmology and Strabismus, J AAPOS. 2016 Apr;20(2):145-7
824. Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS.Long-term side effects of glucocorticoids. Expert Opinon on Drug Safety, Expert Opin Drug Saf. 2016 Apr;15(4):457-65.
825. Queisi M, Zein M, Lamba N, Meese H, Foster CS. Update on Ocular Cicatricial Pemphigoid and Emerging Treatments. Surv Ophthalmol. 2016 May-Jun;61(3):314-7.
826. Cocho L, Gonzalez-Gonzalez LA, Molina-Prat N, Doctor P, Sainz-de-la-Maza M, Foster CS. Scleritis in patients with granulomatosis with polyangiitis (Wegener). British Journal of Ophthalmology. 2016 July;100(8):1062-5
827. Freitas-Neto CA, Oréfice F, Costa RA, Oréfice JL, Dhanireddy S, Maghsoudlou A, Foster CS. Multimodal Imaging Assisting the Early Diagnosis of Cat-Scratch Neuroretinitis. Seminars in Ophthalmology, 2016 August; 31(5):495-8
828. Sainz-de-la-Maza M, Molina-Prat N, Gonzalez-Gonzalez LA, Doctor P, Tauber J, Foster CS. Scleritis Associated with Relapsing Polychondritis. British Journal of Ophthalmology, 2016 August; 100(9):1290-4
829. Oray M, Khachatryan N, Ebrahimiadib N, Abu Samra K, Lee S, Foster CS. Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study. Graefes Arch Clin Exp Ophthalmol, 2016 September; 254(9):1841-9
830. Wolfgang Hueber, Dhavalkumar D. Patel, Thaddeus Dryja, Andrew M. Wright, Irina Koroleva, Gerard Bruin, Christian Antoni, Zoe Draelos, Michael H. Gold, the Psoriasis Study Group, Patrick Durez, Paul P. Tak, Juan J. Gomez-Reino, the Rheumatoid Arthritis Study Group, C. Stephen Foster, Rosa Y. Kim, C. Michael Samson, Naomi S. Falk, David S. Chu, David Callanan, Quan Dong Nguyen, the Uveitis Study Group, Kristine Rose, Asifa Haider, Franco Di Padova1. Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis. Sci. Transl. Med., 2010 October 6;2(52):52ra72
831. Cao JH, Oray M, Cocho L, Foster CS. Rituximab in the Treatment of Refractory Non-Infectious Scleritis. American Journal of Ophthalmology. 2016
832. Durrani K, Kempen JH, Ying GS, Kacmaz RO, Artornsombuth P, Rosenbaum JT, Suhler EB, Thorne JE, Jabs DA, Levy-Clarke GA, Bussenblatt RB, Foster CS. Adalimumab for Ocular Inflammation. Ocular Immunology and Inflammation. 2016 March 22; 25(3): 404-412
833. Cao JH, Silpa-Archa S, Freitas-Neto CA, Foster CS. Birdshot Chorioretinitis Lesions on Indocyanine Green Angiography as an Indicator of Disease Activity. Retina. 2016; 36(9):1751-1757
834. Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD. Remission of Intermediate Uveitis: Incidence and Predictive Factors. American Journal of Ophthalmology. 2016 April; 164:110-117
835. Holbrook JT, Sugar EA, Burke AE, Vitale AT, Thorne JE, Davis J, Jabs DA, for the Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. American Journal of Ophthalmology. 2016 April; 164: 29-36
836. Maleki A, Cao JH, Silpa-Archa S, Foster CS. Visual Outcome and Poor Prognostic Factors in Isolated Idiopathic Retinal Vasculitis. Retina. 2016; 36: 1979-1985
837. Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenc V, Zarranz-Ventura J, Sala-Puigdollers A, Matas J, Adan A, Foster CS. Interleukin-22 serum levels are elevated in active scleritis. Acta Ophthalmologica. 2016; 94:e395-e399
838. Silpa-Archa S, Maleki A, Roohipoor R, Preble J, Foster CS. Analysis of Three-dimensional choroidal volume with enhanced depth imaging findings in patients with birdshot retinochoroidopathy. Retina. 2016; 36:1758-1766
839. Oray M, Meese H, Foster CS. Diagnosis and Management of Scleritis: Current Status and Future Prospects. Expert Rev. Clin. Immunol. Aug 2016.
840. Suelves AM, Lamba N, Meese HK, Foster CS, JM González-Martín; M Díaz-Llopis, Christen WM. Nuclear cataract as an early predictive factor for recalcitrant juvenile idiopathic arthritis-associated uveitis. Journal of the American Association for Pediatric Ophthalmology and Strabismus. 2016; 20:232-238
841. Robert MC, Črnej A, Shen LQ, Papaliodis GN, Dana R, Foster CS, Chodosh J, Dohlman CH. Infliximab after Boston Keratoprosthesis in Stevens-Johnson Syndrome: An Update. Ocular Immunology and Inflammation. 2017;25(3): 413-417
842. Silpa-Archa S, Oray M, Preble JM, Foster CS. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases. Acta Ophthalmologica. 2016; 94: e400-e406
843. Kubaisi B, Abu Samra K, Foster CS. Granulomatosis with Polyangiitis (Wegener’s disease): An Updated Review of Ocular Disease Manifestations. Intractable and Rare Disease Research. 2016; 5(2):61-69
844. Silpa Archa S, Preble JM, Foster CS. Vogt-Koyanagi-Harada Syndrome: Perspectives for Immunogenetics, Multimodal Imaging and Therapeutic Options. Autoimmunity Reviews. 2016; 15: 809-819
845. Sahawneh H, Maleki A, Foster CS. Efficacy and Safety of intravenous immunoglobulin therapy in refractory uveitis. 2016; 1(1): 1-4
846. Ebrahimiadib N, Mdjtahedi BS, Roohipoor R, Anesi SD, Foster CS. Successful Treatment Strategies in Granulomatosis with Polyangiitis associated Peripheral Ulcerative Keratitis. Cornea. 2016; 35(11): 1459-1465
847. Silpa-archa S, Lee JJ, Boonsopon S, Lizarraga M, Preble JP, Sujirarat D, Patel P, Foster CS. Poor Prognostic factors in patients with birdshot retinochoroidopathy. Retina. 2016; 36: 2220-2226
848. Hinkle DM, Kruh-Garcia NA, Kruh JN, Broccardo C, Doctor P, Foster CS. Moxifloxacin concentration and proteome analysis of aqueous humor in human uveitis associated with oral moxifloxacin therapy. The Open Ophthalmology Journal. 2017; 11: 107-116
849. Maleki A, Swan RT, Lasave AF, Ma L, Foster CS. Selective Laser Trabeculoplasty in Controlled Uveitis with Steroid-Induced Glaucoma. Ophthalmology. 2016; 123(12): 2630-2632
850. Ahmed AH, Kubaisi B, Foster CS. Serpiginous Choroiditis. JAMA Ophthalmology. 2017 April 1;135(4):e165495
 |
|
|
|
